These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2653979)

  • 1. [General and specific laboratory parameters within the scope of tumor after-care in gynecologic malignancies and breast cancer].
    Kreienberg R
    Gynakologe; 1989 Feb; 22(1):55-62. PubMed ID: 2653979
    [No Abstract]   [Full Text] [Related]  

  • 2. [ What kind of follow-up after cancer of the breast or genital organs?].
    Delaloye JF
    Rev Med Suisse Romande; 1994 Sep; 114(9):789-91. PubMed ID: 7939111
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possibilities and goals in after care of breast cancer].
    Seifert M; Adler A; Obermair A; Hartmann B; Denison U; Kubista E; Sevelda P
    Gynakol Rundsch; 1991; 31 Suppl 2():309-11. PubMed ID: 1665141
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor markers for the diagnosis, prognosis, treatment and follow-up of gynaecological tumors.
    Ulsperger E; Karrer K
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():33-43. PubMed ID: 3074225
    [No Abstract]   [Full Text] [Related]  

  • 5. [What did tumor markers bring us?].
    Seitzer D
    Zentralbl Gynakol; 1991; 113(7):389-96. PubMed ID: 2063633
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pre- and post-therapeutic serum concentrations of mucin-like carcinoma-associated antigen in patients with breast cancer].
    Fuith LC; Artner-Dworzak E; Schröcksnadel H; Müller-Holzner E; Daxenbichler G; Heim K
    Gynakol Rundsch; 1989; 29 Suppl 2():397-9. PubMed ID: 2613061
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased levels of tumor markers in the follow-up of 400 patients with breast cancer without recurrence or metastasis: interpretation of false-positive results.
    Zervoudis S; Peitsidis P; Iatrakis G; Panourgias E; Koureas A; Navrozoglou I; Dubois JB
    J BUON; 2007; 12(4):487-92. PubMed ID: 18067207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor markers in gynecology].
    Fuith LC; Artner-Dworzak E; Daxenbichler G
    Wien Klin Wochenschr; 1989 Jul; 101(14):489-91. PubMed ID: 2672608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor markers in breast cancer.
    Tondini C; Hayes DF; Kufe DW
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):653-74. PubMed ID: 2691493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of CA15-3 in human breast cancer].
    Nihei M; Nomizu T; Tsuchiya A; Abe R
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):987-95. PubMed ID: 3480326
    [No Abstract]   [Full Text] [Related]  

  • 11. [The place of tumor markers in breast and gynecologic neoplasms].
    Gosselin P; Cazin JL; Demaille MC; Sulman C
    Rev Fr Gynecol Obstet; 1988; 83(7-9):535-40. PubMed ID: 3057569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunologic tumor diagnosis].
    Schmolke B
    Z Lymphol; 1990 Dec; 14(2):58-61. PubMed ID: 2087871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibilities and limits of the study of tumor markers in the after-care of patients with ovarian cancer].
    Kreienberg R
    Gynakologe; 1986 Sep; 19(3):178-85. PubMed ID: 3770529
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mucinous carcinoma-associated antigen (MCA) in ovarian cancer].
    Hanzal E; Kölbl H; Gitsch G; Bieglmayer C
    Gynakol Rundsch; 1990; 30 Suppl 1():68-70. PubMed ID: 2079303
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preliminary experience with BCM-IMx as a pretreatment marker of breast tumors].
    Fernández Llana B; Fernández Fernández M; Suárez B; Allende MT
    Rev Clin Esp; 1992 Mar; 190(4):209. PubMed ID: 1589619
    [No Abstract]   [Full Text] [Related]  

  • 16. [Modified breast cancer after care].
    Jäger W; Merkle E; Tulusan AH; Lang N
    Gynakol Rundsch; 1991; 31 Suppl 2():296-9. PubMed ID: 1665139
    [No Abstract]   [Full Text] [Related]  

  • 17. [Squamous cell carcinoma antigen--a useful tumor marker for gynecologic squamous cell cancers?].
    Neunteufel W; Tatra G; Reinthaller A; Bieglmayer C
    Gynakol Rundsch; 1988; 28 Suppl 2():201-2. PubMed ID: 3234918
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mucoid carcinoma antigen--a new tumor marker].
    Bieglmayer C; Szepesi T; Neunteufel W
    Gynakol Rundsch; 1988; 28 Suppl 2():203-5. PubMed ID: 3234919
    [No Abstract]   [Full Text] [Related]  

  • 19. [Breast carcinoma--revision of follow-up recommendations. 2: Special diagnostic value of bone scintigraphy, thoracic radiography, liver ultrasonic, mammography and laboratory tests].
    Sauer H; Hölzel D
    Fortschr Med; 1995 May; 113(14):210-4. PubMed ID: 7607590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor markers and their significance in gynecologic oncology].
    Melchert F; Kreienberg R
    Gynakologe; 1980 Jun; 13(2):74-88. PubMed ID: 6299910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.